Faeth Therapeutics, Inc.

FTH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Jun 16, 2026
3 Jun 16, 2026
4/A Jun 16, 2026
8-K Jun 15, 2026 8-K
EFFECT Jun 12, 2026
4 Jun 12, 2026
4 Jun 12, 2026
4 Jun 12, 2026
S-3/A Jun 10, 2026 S-3/A
8-K Jun 10, 2026 8-K
SCHEDULE 13G/A Jun 3, 2026
10-K/A Jun 2, 2026 10-K/A
S-3/A Jun 2, 2026 S-3/A
4 Jun 1, 2026 FORM 4
4 Jun 1, 2026 FORM 4
DEFA14A May 22, 2026 DEFA14A
8-K May 22, 2026 8-K
DEFA14A May 21, 2026 DEFA14A
8-K May 21, 2026 8-K
4 May 15, 2026 OWNERSHIP DOCUMENT
4 May 15, 2026 OWNERSHIP DOCUMENT
4 May 15, 2026 OWNERSHIP DOCUMENT
3 May 15, 2026 OWNERSHIP DOCUMENT
SCHEDULE 13G May 15, 2026
SCHEDULE 13G May 15, 2026
← Newer Page 2 of 18 · 444 filings Older →